The U.S. Federal Trade Commission has cracked down on clinics that are making claims that certain stem cell therapies can treat a number of serious diseases such as macular degeneration, Parkinson’s disease, autism, cerebral palsy, multiple sclerosis, and heart attacks.
The FTC announced Thursday that it had settled charges of deceptive advertising against two California clinics, Regenerative Medical Group and Telehealth Medical Group. Both clinics are owned by Dr. Bryn Jarald Henderson. According to the FTC, the clinics earned $3.31 million between 2014 and 2017 due to the stem cell therapies offered. The two clinics claimed to offer “amniotic stem cell therapy” for the prevention of the aforementioned diseases. The FTC said that the price of the initial stem cell therapy injections ranged from $9,500 to $15,000. Patients were encouraged to undergo multiple treatments, with follow-up procedures having a price tag between $5,000 and $8,000 each, the FTC said.